Brief: FDA Approves First Oral Drug Indicated To Treat Dermatomyositis In Adults
27/08/2026 20:18
BRIEF-FDA Approves First Oral Drug Indicated To Treat Dermatomyositis In Adults Aug 28 (Reuters) - FDA:
FDA: FDA APPROVES FIRST ORAL DRUG INDICATED TO TREAT DERMATOMYOSITIS IN ADULTS
FDA: LISRAYA IS THE FIRST FDA-APPROVED ORAL TREATMENT OPTION FOR PATIENTS WITH DERMATOMYOSITIS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Roivant Sciences
See all newsU.S. STOCKS ON THE MOVE-Thermo Fisher, CME, Capital One, Northern Trust
Roivant rises as drug succeeds in two late-stage trials for eye disease
Immunovant falls after lupus drug setback
Brief: Roivant Announces Topline Results From Proof-Of-Concept Study Of Imvt-1402 In Cutaneous Lupus Erythematosus
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple